PK/PD studies

Pharmacokinetic (PK) and Pharmacodynamic (PD) assays are the engine room for Lead Optimisation Drug Discovery.

With our combined years of extensive experience delivering programmes into preclinical development, we understand the need for robust, pharmacologically sensitive, high-throughput, multi-modal in-vivo and ex-vivo endpoints that can be put into context with drug exposure levels.

We can offer almost any dosing route and preclinical species that you might require along with a broad range of behavioural end points and tissue / fluid collection capabilities.

Examples include:


pkThis list is not exhaustive, we are always developing new areas of discovery within our preclinical field of expertise. If there is something particular that is not listed here please do contact us.

Start a Conversation

uk flag +44 (0)20 7691 0984

ireland flag +353 (0)1896 42 60

mail contact@transpharmation.co.uk


Copyright

Copyright © 2020 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design

IASP VIRTUAL SERIES ON PAIN & EXPO

The first International Association for the Study of Pain, (IASP) virtual conference is live!

Come and visit Transpharmation’s booth #iaspvirtualseries

View our latest specialist poster on pain; ‘The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type 1 diabetic rodents’ and find out more about our wide-ranging pain expertise.  We look forward to seeing you there.

IASP Footer